• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[化脓性汗腺炎/反向性痤疮:最新进展]

[Hidradenitis suppurativa/acne inversa: An update].

作者信息

Kirschke J, Hessam S, Bechara F G

机构信息

Klinik für Dermatologie, Venerologie und Allergologie, HELIOS St. Elisabeth Klinik Oberhausen, Oberhausen, Deutschland.

出版信息

Hautarzt. 2015 Jun;66(6):413-22. doi: 10.1007/s00105-015-3616-y.

DOI:10.1007/s00105-015-3616-y
PMID:25877488
Abstract

Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory disease characterized by painful nodules, abscesses, fistulas, sinus tracts and scarring, which may lead to severe functional and psychological impairment. Patients often suffer for many years before the right diagnosis is finally made. HS/AI is still a therapeutic challenge. Conservative therapies play a role in mild stages of the disease; however they do not result in healing. Therapy of choice associated with the lowest recurrence rate is a radical wide excision of involved skin.

摘要

化脓性汗腺炎/反向性痤疮(HS/AI)是一种慢性炎症性疾病,其特征为疼痛性结节、脓肿、瘘管、窦道和瘢痕形成,这可能导致严重的功能和心理障碍。患者通常要忍受多年折磨才最终得以确诊。HS/AI仍然是一个治疗难题。保守治疗在疾病的轻度阶段发挥作用;然而,它们无法实现治愈。复发率最低的首选治疗方法是对受累皮肤进行广泛根治性切除。

相似文献

1
[Hidradenitis suppurativa/acne inversa: An update].[化脓性汗腺炎/反向性痤疮:最新进展]
Hautarzt. 2015 Jun;66(6):413-22. doi: 10.1007/s00105-015-3616-y.
2
[Acne inversa].[反向性痤疮]
Hautarzt. 2010 Jan;61(1):39-46. doi: 10.1007/s00105-009-1813-2.
3
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.基于欧洲化脓性汗腺炎指南的化脓性汗腺炎/反向性痤疮循证治疗方法
Rev Endocr Metab Disord. 2016 Sep;17(3):343-351. doi: 10.1007/s11154-016-9328-5.
4
Epidemiologic and clinical features of hidradenitis suppurativa.化脓性汗腺炎的流行病学及临床特征
Semin Cutan Med Surg. 2017 Jun;36(2):42-46. doi: 10.12788/j.sder.2017.019.
5
[Acne inversa/hidradenitis suppurativa: An update].[化脓性汗腺炎/反向性痤疮:最新进展]
Hautarzt. 2017 Dec;68(12):999-1006. doi: 10.1007/s00105-017-4082-5.
6
Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.瑞士化脓性汗腺炎/反向痤疮管理实践推荐
Dermatology. 2017;233(2-3):113-119. doi: 10.1159/000477459. Epub 2017 Jul 7.
7
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.S2k 指南治疗化脓性汗腺炎/反向痤疮 - 简化版。
J Dtsch Dermatol Ges. 2024 Jun;22(6):868-889. doi: 10.1111/ddg.15412. Epub 2024 May 21.
8
Photodynamic therapy for Hidradenitis Suppurativa/acne inversa: Case report.光动力疗法治疗化脓性汗腺炎/反向痤疮:病例报告。
Photodiagnosis Photodyn Ther. 2018 Jun;22:251-252. doi: 10.1016/j.pdpdt.2018.04.014. Epub 2018 Apr 27.
9
[CME Dermatology 23/Answers: Hidradenitis suppurativa].[继续医学教育皮肤科23/答案:化脓性汗腺炎]
Praxis (Bern 1994). 2021 Jun;110(8):471-472. doi: 10.1024/1661-8157/a003694.
10
Hidradenitis Suppurativa.化脓性汗腺炎。
Dermatol Clin. 2023 Jul;41(3):471-479. doi: 10.1016/j.det.2023.02.001. Epub 2023 Apr 15.

引用本文的文献

1
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature.化脓性汗腺炎的癌症风险:文献综述
Clin Cosmet Investig Dermatol. 2025 Mar 18;18:617-626. doi: 10.2147/CCID.S512373. eCollection 2025.
2
A state-of-the-art systematic review of cancer in hidradenitis suppurativa.一项关于化脓性汗腺炎中癌症的最新系统评价。
Ann Med. 2024 Dec;56(1):2382372. doi: 10.1080/07853890.2024.2382372. Epub 2024 Jul 24.
3
[Postoperative wound care with custom-made wound dressings for hidradenitis suppurativa : Wound care after radical excision with secondary wound closure].

本文引用的文献

1
Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement.早期发病型化脓性汗腺炎与更强的遗传易感性和更广泛的受累有关。
J Am Acad Dermatol. 2015 Mar;72(3):485-8. doi: 10.1016/j.jaad.2014.11.017. Epub 2015 Jan 10.
2
[Acne inversa: influence of associated factors in the extent of the disease and the result of surgery].[化脓性汗腺炎:相关因素对疾病范围及手术结果的影响]
Hautarzt. 2014 Jul;65(7):623-7. doi: 10.1007/s00105-014-2839-7.
3
Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa.
[定制伤口敷料用于化脓性汗腺炎的术后伤口护理:根治性切除并二期伤口缝合后的伤口护理]
Dermatologie (Heidelb). 2022 Dec;74(12):994-996. doi: 10.1007/s00105-023-05247-x. Epub 2023 Nov 1.
4
[Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].[化脓性汗腺炎/反向性痤疮——手术选择、重建及与药物治疗的联合应用——最新进展]
Hautarzt. 2021 Aug;72(8):692-699. doi: 10.1007/s00105-021-04864-8. Epub 2021 Jul 6.
5
[Hidradenitis suppurativa/acne inversa in the genitoanal region].[生殖器肛周区域的化脓性汗腺炎/反向性痤疮]
Hautarzt. 2020 Apr;71(4):256-262. doi: 10.1007/s00105-020-04556-9.
6
A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.一种用于化脓性汗腺炎的新型严重程度评估评分系统。
JAMA Dermatol. 2018 Mar 1;154(3):330-335. doi: 10.1001/jamadermatol.2017.5890.
7
[Surgical treatment options for hidradenitis suppurativa/acne inversa].[化脓性汗腺炎/反向性痤疮的手术治疗选择]
Hautarzt. 2018 Feb;69(2):149-161. doi: 10.1007/s00105-017-4114-1.
8
[Acne inversa/hidradenitis suppurativa: An update].[化脓性汗腺炎/反向性痤疮:最新进展]
Hautarzt. 2017 Dec;68(12):999-1006. doi: 10.1007/s00105-017-4082-5.
9
Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.miRNA-155、miRNA-223、miRNA-31、miRNA-21、miRNA-125b 和 miRNA-146a 在化脓性汗腺炎炎症通路中的表达。
Inflammation. 2017 Apr;40(2):464-472. doi: 10.1007/s10753-016-0492-2.
3207例化脓性汗腺炎患者的精神共病情况
J Eur Acad Dermatol Venereol. 2015 Feb;29(2):371-376. doi: 10.1111/jdv.12567. Epub 2014 Jun 9.
4
A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma.1例III期家族性化脓性汗腺炎患者接受3个疗程英夫利昔单抗治疗后死于转移性鳞状细胞癌。
Dermatol Online J. 2014 Mar 17;20(3):doj_21764.
5
Use of biological treatments in patients with hidradenitis suppurativa.化脓性汗腺炎患者生物治疗的应用。
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):56-60. doi: 10.1111/jdv.12438. Epub 2014 Mar 13.
6
Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice?化脓性汗腺炎的细菌学——哪些抗生素是治疗的首选?
Acta Derm Venereol. 2014 Nov;94(6):699-702. doi: 10.2340/00015555-1841.
7
Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device.应用内置式负压辅助闭合装置处理化脓性汗腺炎创面。
Plast Reconstr Surg. 2014 Mar;133(3):370e-377e. doi: 10.1097/PRS.0000000000000080.
8
Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients.化脓性汗腺炎(反向性痤疮)的微生物学:27例患者的组织学研究
APMIS. 2014 Sep;122(9):804-9. doi: 10.1111/apm.12220. Epub 2014 Jan 30.
9
An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.阿那白滞素治疗中重度化脓性汗腺炎的开放标签研究。
J Am Acad Dermatol. 2014 Feb;70(2):243-51. doi: 10.1016/j.jaad.2013.09.044. Epub 2013 Dec 4.
10
Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.化脓性汗腺炎:基于350多名化脓性汗腺炎患者对可能的药物治疗的实用综述
Dermatol Online J. 2013 Apr 15;19(4):1.